Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6
20 April 2021 - 10:15PM
Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive
therapeutic ultrasonic medical devices and regenerative products
that enhance clinical outcomes, announced today that it will report
its fiscal 2021 third quarter financial results after the market
closes on Thursday, May 6, 2021. The Company will host a conference
call and webcast at 4:30 p.m. ET that day to review the results.
Both the call and webcast are open to the general public.
To access the conference call, interested
parties may dial 866-248-8441 (domestic) or 323-289-6576
(international) conference ID 9869811. Participants may also listen
to a live webcast of the call through the “Events and
Presentations” section under “Investor Relations” on Misonix’s
website at www.misonix.com. A webcast replay will be available for
30 days following the live event at www.misonix.com.
Please call five minutes in advance to ensure
that you are connected. Questions and answers will be taken only
from participants on the conference call. For the webcast, please
allow 15 minutes to register, download and install any necessary
software.
About Misonix, Inc.Misonix,
Inc. (Nasdaq: MSON) is a provider of minimally invasive
therapeutic ultrasonic medical devices and regenerative tissue
products. Its surgical team markets and sells BoneScalpel and
SonaStar, which facilitate precise bone sculpting and removal of
soft and hard tumors and tissue, primarily in the areas of
neurosurgery, orthopedic, plastic and maxillo-facial surgery. The
Company's wound team markets and sells TheraSkin, Therion,
TheraGenesis and SonicOne to debride, treat and heal chronic and
traumatic wounds in inpatient, outpatient and physician office
sites of service. At Misonix, Better Matters! That is why
throughout the Company’s history, Misonix has maintained
its commitment to medical technology innovation and the development
of products that radically improve outcomes for patients.
Additional information is available on the Company's web site at
www.misonix.com.
Contact: |
|
Joe Dwyer |
Norberto Aja, Jennifer
Neuman |
Chief Financial Officer |
JCIR |
Misonix, Inc. |
212-835-8500 or
mson@jcir.com |
631-927-9113 |
|
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Dec 2024 to Jan 2025
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about Misonix Inc (NASDAQ): 0 recent articles
More News Articles